3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Refractory/Relapse Neuroblastoma
1
Precursor Cell Lymphoblastic Leukemia-Lymphoma
1
Neuroendocrine Tumors
1
Neoplasms, Squamous Cell
1
Neoplasms
1
Nasopharyngeal Carcinoma
1
Lymphoma
1
Lung Neoplasms
1
Hysterectomies for Low- or Intermediate-risk Endometrial Carcinoma
1
Esophageal Neoplasms
1
Carcinoma, Non-Small-Cell Lung
1
Breast Neoplasms
1
Interventions
Cyclophosphamide
48
Rituximab
32
fludarabine
29
Doxorubicin
14
Specimen Handling
13
Magnetic Resonance Spectroscopy
13
Vincristine
12
Prednisone
12
pirtobrutinib
11
fludarabine phosphate
10
Etoposide
10
Bendamustine Hydrochloride
10
Immunotherapy, Adoptive
9
obinutuzumab
8
Lenalidomide
8
Biopsy
8
venetoclax
7
polatuzumab vedotin
7
pembrolizumab
7
glofitamab
7
zanubrutinib
6
Dexamethasone
6
tafasitamab
5
ibrutinib
5
etoposide phosphate
5
acalabrutinib
5
Leukapheresis
5
tazemetostat
4
loncastuximab tesirine
4
Nivolumab
4
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Lymphoma, B-Cell
×
Biological Products
×
1 year
×
Clear all
No trials found.